Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 591

1.

Efficacy and Safety of Bi-weekly Pegfilgrastim for Dose-dense Chemotherapy-induced Neutropenia in Breast Cancer Patients.

Mori H, Kubo M, Kai M, Kurata K, Yamada M, Nakamura M.

Anticancer Res. 2018 Jul;38(7):4381-4386. doi: 10.21873/anticanres.12740.

PMID:
29970577
2.

Catumaxomab with Activated T-cells Efficiently Lyses Chemoresistant EpCAM-positive Triple-negative Breast Cancer Cell Lines.

Kubo M, Umebayashi M, Kurata K, Mori H, Kai M, Onishi H, Katano M, Nakamura M, Morisaki T.

Anticancer Res. 2018 Jul;38(7):4273-4279. doi: 10.21873/anticanres.12724.

PMID:
29970561
3.

Visualizing Energy Charge in Breast Carcinoma Tissues by MALDI Mass-spectrometry Imaging Profiles of Low-molecular-weight Metabolites.

Torata N, Kubo M, Miura D, Ohuchida K, Mizuuchi Y, Fujimura Y, Hayakawa E, Kai M, Oda Y, Mizumoto K, Hashizume M, Nakamura M.

Anticancer Res. 2018 Jul;38(7):4267-4272. doi: 10.21873/anticanres.12723.

PMID:
29970560
4.

Surface microstructures are associated with mutational intratumoral heterogeneity in colorectal tumors.

Harada T, Yamamoto E, Yamano HO, Aoki H, Matsushita HO, Yoshikawa K, Takagi R, Harada E, Tanaka Y, Yoshida Y, Eizuka M, Yorozu A, Sudo G, Kitajima H, Niinuma T, Kai M, Sasaki Y, Tokino T, Sugai T, Nakase H, Suzuki H.

J Gastroenterol. 2018 Jun 11. doi: 10.1007/s00535-018-1481-z. [Epub ahead of print]

PMID:
29948303
5.

BRCAness Combined With a Family History of Cancer Is Associated With a Poor Prognosis for Breast Cancer Patients With a High Risk of BRCA Mutations.

Mori H, Kubo M, Kai M, Velasquez VV, Kurata K, Yamada M, Okido M, Kuroki S, Oda Y, Nakamura M.

Clin Breast Cancer. 2018 Jun 2. pii: S1526-8209(18)30022-3. doi: 10.1016/j.clbc.2018.05.008. [Epub ahead of print]

PMID:
29941390
6.

Biodistribution and Toxicity of Micellar Platinum Nanoparticles in Mice via Intravenous Administration.

Brown AL, Kai MP, DuRoss AN, Sahay G, Sun C.

Nanomaterials (Basel). 2018 Jun 7;8(6). pii: E410. doi: 10.3390/nano8060410.

7.

Author's Reply.

Kai M, Tasaki M, Chino N.

J Minim Invasive Gynecol. 2018 May 28. pii: S1553-4650(18)30274-7. doi: 10.1016/j.jmig.2018.05.019. [Epub ahead of print] No abstract available.

PMID:
29852295
8.

Epigenetic silencing of miR-200b is associated with cisplatin resistance in bladder cancer.

Shindo T, Niinuma T, Nishiyama N, Shinkai N, Kitajima H, Kai M, Maruyama R, Tokino T, Masumori N, Suzuki H.

Oncotarget. 2018 May 11;9(36):24457-24469. doi: 10.18632/oncotarget.25326. eCollection 2018 May 11.

9.

Subtypes of the Type II Pit Pattern Reflect Distinct Molecular Subclasses in the Serrated Neoplastic Pathway.

Aoki H, Yamamoto E, Yamano HO, Sugai T, Kimura T, Tanaka Y, Matsushita HO, Yoshikawa K, Takagi R, Harada E, Nakaoka M, Yoshida Y, Harada T, Sudo G, Eizuka M, Yorozu A, Kitajima H, Niinuma T, Kai M, Nojima M, Suzuki H, Nakase H.

Dig Dis Sci. 2018 Jul;63(7):1920-1928. doi: 10.1007/s10620-018-5016-5. Epub 2018 Mar 15.

PMID:
29546645
10.

Antimicrobial resistance in leprosy: results of the first prospective open survey conducted by a WHO surveillance network for the period 2009-15.

Cambau E, Saunderson P, Matsuoka M, Cole ST, Kai M, Suffys P, Rosa PS, Williams D, Gupta UD, Lavania M, Cardona-Castro N, Miyamoto Y, Hagge D, Srikantam A, Hongseng W, Indropo A, Vissa V, Johnson RC, Cauchoix B, Pannikar VK, Cooreman EAWD, Pemmaraju VRR, Gillini L; WHO surveillance network of antimicrobial resistance in leprosy.

Clin Microbiol Infect. 2018 Mar 1. pii: S1198-743X(18)30197-6. doi: 10.1016/j.cmi.2018.02.022. [Epub ahead of print]

11.

Clinical Features and Surgical Management of Cerebellopontine Angle Cholesteatoma That Presented as Trigeminal Neuralgia.

Kai M, Yongjie L.

World Neurosurg. 2018 Jul;115:e7-e12. doi: 10.1016/j.wneu.2018.02.047. Epub 2018 Feb 15.

PMID:
29454958
12.

Evolutionary stability of antibiotic protection in a defensive symbiosis.

Engl T, Kroiss J, Kai M, Nechitaylo TY, Svatoš A, Kaltenpoth M.

Proc Natl Acad Sci U S A. 2018 Feb 27;115(9):E2020-E2029. doi: 10.1073/pnas.1719797115. Epub 2018 Feb 14.

PMID:
29444867
13.

Epigenetic silencing of SMOC1 in traditional serrated adenoma and colorectal cancer.

Aoki H, Yamamoto E, Takasawa A, Niinuma T, Yamano HO, Harada T, Matsushita HO, Yoshikawa K, Takagi R, Harada E, Tanaka Y, Yoshida Y, Aoyama T, Eizuka M, Yorozu A, Kitajima H, Kai M, Sawada N, Sugai T, Nakase H, Suzuki H.

Oncotarget. 2017 Dec 20;9(4):4707-4721. doi: 10.18632/oncotarget.23523. eCollection 2018 Jan 12.

14.

Phylogenomics and antimicrobial resistance of the leprosy bacillus Mycobacterium leprae.

Benjak A, Avanzi C, Singh P, Loiseau C, Girma S, Busso P, Fontes ANB, Miyamoto Y, Namisato M, Bobosha K, Salgado CG, da Silva MB, Bouth RC, Frade MAC, Filho FB, Barreto JG, Nery JAC, Bührer-Sékula S, Lupien A, Al-Samie AR, Al-Qubati Y, Alkubati AS, Bretzel G, Vera-Cabrera L, Sakho F, Johnson CR, Kodio M, Fomba A, Sow SO, Gado M, Konaté O, Stefani MMA, Penna GO, Suffys PN, Sarno EN, Moraes MO, Rosa PS, Baptista IMFD, Spencer JS, Aseffa A, Matsuoka M, Kai M, Cole ST.

Nat Commun. 2018 Jan 24;9(1):352. doi: 10.1038/s41467-017-02576-z.

15.

Bioderived DNA Nanomachines for Potential Uses in Biosensing, Diagnostics, and Therapeutic Applications.

Angell C, Kai M, Xie S, Dong X, Chen Y.

Adv Healthc Mater. 2018 Apr;7(8):e1701189. doi: 10.1002/adhm.201701189. Epub 2018 Jan 19. Review.

PMID:
29350489
16.

Evaluation of Urinary DNA Methylation as a Marker for Recurrent Bladder Cancer: A 2-Center Prospective Study.

Shindo T, Shimizu T, Nojima M, Niinuma T, Maruyama R, Kitajima H, Kai M, Itoh N, Suzuki H, Masumori N.

Urology. 2018 Mar;113:71-78. doi: 10.1016/j.urology.2017.11.025. Epub 2017 Nov 28.

PMID:
29196070
17.

Downregulation of miR-186 is associated with metastatic recurrence of gastrointestinal stromal tumors.

Niinuma T, Kai M, Kitajima H, Yamamoto E, Harada T, Maruyama R, Nobuoka T, Nishida T, Kanda T, Hasegawa T, Tokino T, Sugai T, Shinomura Y, Nakase H, Suzuki H.

Oncol Lett. 2017 Nov;14(5):5703-5710. doi: 10.3892/ol.2017.6911. Epub 2017 Sep 8.

18.

Dual mTOR Kinase Inhibitor MLN0128 Sensitizes HR+/HER2+ Breast Cancer Patient-Derived Xenografts to Trastuzumab or Fulvestrant.

Hsu PY, Wu VS, Kanaya N, Petrossian K, Hsu HK, Nguyen D, Schmolze D, Kai M, Liu CY, Lu H, Chu P, Vito CA, Kruper L, Mortimer J, Chen S.

Clin Cancer Res. 2018 Jan 15;24(2):395-406. doi: 10.1158/1078-0432.CCR-17-1983. Epub 2017 Oct 27.

PMID:
29079660
19.

Evaluation of a Spray-type, Novel Dextrin Hydrogel Adhesion Barrier Under Laparoscopic Conditions in a Porcine Uterine Horn Adhesion Model.

Kai M, Maeda K, Tasaki M, Kira S, Nakamura S, Chino N, Hagiwara H, Nishida H, Kawanishi T.

J Minim Invasive Gynecol. 2018 Mar - Apr;25(3):447-454. doi: 10.1016/j.jmig.2017.09.023. Epub 2017 Oct 10.

PMID:
29030291
20.

[Efficacy of GC Therapy for the Patient of iTNBC with Resistance to TAC Therapy].

Yamada M, Kubo M, Kai M, Yamamoto H, Nakamura M.

Gan To Kagaku Ryoho. 2017 Aug;44(8):703-705. Japanese.

PMID:
28860445
21.

Malperfusion in Type A Dissection: Consider Reperfusion First.

Goldberg JB, Lansman SL, Kai M, Tang GHL, Malekan R, Spielvogel D.

Semin Thorac Cardiovasc Surg. 2017 Summer;29(2):181-185. doi: 10.1053/j.semtcvs.2016.10.017. Epub 2016 Nov 11. Review.

PMID:
28823325
22.

Pharmacoresistant epileptic eyelid twitching in a child with a mutation in SYNGAP1.

Okazaki T, Saito Y, Hiraiwa R, Saitoh S, Kai M, Adachi K, Nishimura Y, Nanba E, Maegaki Y.

Epileptic Disord. 2017 Sep 1;19(3):339-344. doi: 10.1684/epd.2017.0922.

PMID:
28721930
23.

Gemcitabine enhances the transport of nanovector-albumin-bound paclitaxel in gemcitabine-resistant pancreatic ductal adenocarcinoma.

Borsoi C, Leonard F, Lee Y, Zaid M, Elganainy D, Alexander JF, Kai M, Liu YT, Kang Y, Liu X, Koay EJ, Ferrari M, Godin B, Yokoi K.

Cancer Lett. 2017 Sep 10;403:296-304. doi: 10.1016/j.canlet.2017.06.026. Epub 2017 Jul 4.

PMID:
28687352
24.

Versatile DNA Origami Nanostructures in Simplified and Modular Designing Framework.

Cui Y, Chen R, Kai M, Wang Y, Mi Y, Wei B.

ACS Nano. 2017 Aug 22;11(8):8199-8206. doi: 10.1021/acsnano.7b03187. Epub 2017 Jul 6.

PMID:
28654269
25.

Effects of discrete bioactive microbial volatiles on plants and fungi.

Piechulla B, Lemfack MC, Kai M.

Plant Cell Environ. 2017 Oct;40(10):2042-2067. doi: 10.1111/pce.13011. Epub 2017 Aug 24. Review.

PMID:
28643880
26.

Tumor progression effects on drug vector access to tumor-associated capillary bed.

Kiseliovas V, Milosevic M, Kojic M, Mazutis L, Kai M, Liu YT, Yokoi K, Ferrari M, Ziemys A.

J Control Release. 2017 Sep 10;261:216-222. doi: 10.1016/j.jconrel.2017.05.031. Epub 2017 May 31.

PMID:
28576640
27.

Exploring bacterial interspecific interactions for discovery of novel antimicrobial compounds.

Tyc O, de Jager VCL, van den Berg M, Gerards S, Janssens TKS, Zaagman N, Kai M, Svatos A, Zweers H, Hordijk C, Besselink H, de Boer W, Garbeva P.

Microb Biotechnol. 2017 Jul;10(4):910-925. doi: 10.1111/1751-7915.12735. Epub 2017 May 29.

28.

A lard-rich high-fat diet increases hepatic peroxisome proliferator-activated receptors in endotoxemic rats.

Kai M, Miyoshi M, Fujiwara M, Nishiyama Y, Inoue T, Maeshige N, Hamada Y, Usami M.

J Surg Res. 2017 May 15;212:22-32. doi: 10.1016/j.jss.2016.11.048. Epub 2016 Dec 7.

PMID:
28550910
29.

RNA-binding protein RBM14 regulates dissociation and association of non-homologous end joining proteins.

Simon NE, Yuan M, Kai M.

Cell Cycle. 2017 Jun 18;16(12):1175-1180. doi: 10.1080/15384101.2017.1317419. Epub 2017 Apr 20.

30.

Establishment of a new initial dose plan for vancomycin using the generalized linear mixed model.

Kourogi Y, Ogata K, Takamura N, Tokunaga J, Setoguchi N, Kai M, Tanaka E, Chiyotanda S.

Theor Biol Med Model. 2017 Apr 8;14(1):8. doi: 10.1186/s12976-017-0054-9.

31.

Epigenetic silencing of diacylglycerol kinase gamma in colorectal cancer.

Kai M, Yamamoto E, Sato A, Yamano HO, Niinuma T, Kitajima H, Harada T, Aoki H, Maruyama R, Toyota M, Hatahira T, Nakase H, Sugai T, Yamashita T, Toyota M, Suzuki H.

Mol Carcinog. 2017 Jul;56(7):1743-1752. doi: 10.1002/mc.22631. Epub 2017 Mar 6.

PMID:
28218473
32.

Rikkunshito prevents paclitaxel-induced peripheral neuropathy through the suppression of the nuclear factor kappa B (NFκB) phosphorylation in spinal cord of mice.

Kamei J, Hayashi S, Sakai A, Nakanishi Y, Kai M, Ikegami M, Ikeda H.

PLoS One. 2017 Feb 9;12(2):e0171819. doi: 10.1371/journal.pone.0171819. eCollection 2017.

33.

The combination of PD-L1 expression and decreased tumor-infiltrating lymphocytes is associated with a poor prognosis in triple-negative breast cancer.

Mori H, Kubo M, Yamaguchi R, Nishimura R, Osako T, Arima N, Okumura Y, Okido M, Yamada M, Kai M, Kishimoto J, Oda Y, Nakamura M.

Oncotarget. 2017 Feb 28;8(9):15584-15592. doi: 10.18632/oncotarget.14698.

34.

Fluorescence assay of dihydroorotate dehydrogenase that may become a cancer biomarker.

Yin S, Kabashima T, Zhu Q, Shibata T, Kai M.

Sci Rep. 2017 Jan 13;7:40670. doi: 10.1038/srep40670.

35.

More Attention Should Be Paid to Abnormalities of Circadian Blood Pressure Rhythm in Heart Failure Patients.

Kai M, Kai H.

Circ J. 2017 Jan 25;81(2):153-154. doi: 10.1253/circj.CJ-16-1269. Epub 2016 Dec 28. No abstract available.

36.

TET1 Depletion Induces Aberrant CpG Methylation in Colorectal Cancer Cells.

Kai M, Niinuma T, Kitajima H, Yamamoto E, Harada T, Aoki H, Maruyama R, Toyota M, Sasaki Y, Sugai T, Tokino T, Nakase H, Suzuki H.

PLoS One. 2016 Dec 15;11(12):e0168281. doi: 10.1371/journal.pone.0168281. eCollection 2016.

37.

BRCAness as a Biomarker for Predicting Prognosis and Response to Anthracycline-Based Adjuvant Chemotherapy for Patients with Triple-Negative Breast Cancer.

Mori H, Kubo M, Nishimura R, Osako T, Arima N, Okumura Y, Okido M, Yamada M, Kai M, Kishimoto J, Miyazaki T, Oda Y, Otsuka T, Nakamura M.

PLoS One. 2016 Dec 15;11(12):e0167016. doi: 10.1371/journal.pone.0167016. eCollection 2016.

38.

Evidence-based clinical practice guidelines for cholelithiasis 2016.

Tazuma S, Unno M, Igarashi Y, Inui K, Uchiyama K, Kai M, Tsuyuguchi T, Maguchi H, Mori T, Yamaguchi K, Ryozawa S, Nimura Y, Fujita N, Kubota K, Shoda J, Tabata M, Mine T, Sugano K, Watanabe M, Shimosegawa T.

J Gastroenterol. 2017 Mar;52(3):276-300. doi: 10.1007/s00535-016-1289-7. Epub 2016 Dec 10. Review.

PMID:
27942871
39.

Local phytochemical response of Musa acuminata × balbisiana Colla cv. 'Bluggoe' (ABB) to colonization by Sternorrhyncha.

Hölscher D, Vollrath A, Kai M, Dhakshinamoorthy S, Menezes RC, Svatoš A, Schubert US, Buerkert A, Schneider B.

Phytochemistry. 2017 Jan;133:26-32. doi: 10.1016/j.phytochem.2016.10.007. Epub 2016 Nov 11.

PMID:
27839785
40.

Mutations in the drug resistance-determining region of Mycobacterium lepromatosis isolated from leprosy patients in Mexico.

Kai M, Fafutis-Morris M, Miyamoto Y, Mukai T, Mayorga-Rodriguez J, Rodriguez-Castellanos MA, Martínez-Guzman MA, Matsuoka M.

J Dermatol. 2016 Nov;43(11):1345-1349. doi: 10.1111/1346-8138.13483. Epub 2016 Jun 27.

PMID:
27345334
41.

Development of the Virtual Physical Assessment Learning Material That Allows the Learners to Check Drug Efficacy and Early Detection of Adverse Effects through Virtual Experience.

Tokunaga J, Takamura N, Kourogi Y, Imada M, Kozasa A, Komori K, Ono C, Nishimura A, Ogata K, Setoguchi N, Matsuoka T, Kai M, Sato K, Arimori K.

Yakugaku Zasshi. 2016;136(10):1439-1444.

42.

Novel volatiles of skin-borne bacteria inhibit the growth of Gram-positive bacteria and affect quorum-sensing controlled phenotypes of Gram-negative bacteria.

Lemfack MC, Ravella SR, Lorenz N, Kai M, Jung K, Schulz S, Piechulla B.

Syst Appl Microbiol. 2016 Dec;39(8):503-515. doi: 10.1016/j.syapm.2016.08.008. Epub 2016 Sep 27.

PMID:
27720237
43.

Clinical Diagnosis of Mendelian Disorders Using a Comprehensive Gene-Targeted Panel Test for Next-Generation Sequencing.

Okazaki T, Murata M, Kai M, Adachi K, Nakagawa N, Kasagi N, Matsumura W, Maegaki Y, Nanba E.

Yonago Acta Med. 2016 Jun 29;59(2):118-25. eCollection 2016 Jun.

44.

Profiling of Intracellular Metabolites: An Approach to Understanding the Characteristic Physiology of Mycobacterium leprae.

Miyamoto Y, Mukai T, Matsuoka M, Kai M, Maeda Y, Makino M.

PLoS Negl Trop Dis. 2016 Aug 1;10(8):e0004881. doi: 10.1371/journal.pntd.0004881. eCollection 2016 Aug.

45.

Aortic surgery in pregnancy.

Lansman SL, Goldberg JB, Kai M, Tang GH, Malekan R, Spielvogel D.

J Thorac Cardiovasc Surg. 2017 Feb;153(2):S44-S48. doi: 10.1016/j.jtcvs.2016.06.015. Epub 2016 Jun 24.

PMID:
27431443
46.

Relationship Between Noncoding RNA Dysregulation and Epigenetic Mechanisms in Cancer.

Suzuki H, Maruyama R, Yamamoto E, Niinuma T, Kai M.

Adv Exp Med Biol. 2016;927:109-35. doi: 10.1007/978-981-10-1498-7_4. Review.

PMID:
27376733
47.

Early and Delayed Induction of DSBs by Nontargeted Effects in ICR Mouse Lymphocytes after In Vivo X Irradiation.

Ojima M, Iwashita K, Kashino G, Kobashigawa S, Sasano N, Takeshita A, Ban N, Kai M.

Radiat Res. 2016 Jul;186(1):65-70. doi: 10.1667/RR14053.1. Epub 2016 Jun 28.

PMID:
27351761
48.

A genomic screen for long noncoding RNA genes epigenetically silenced by aberrant DNA methylation in colorectal cancer.

Kumegawa K, Maruyama R, Yamamoto E, Ashida M, Kitajima H, Tsuyada A, Niinuma T, Kai M, Yamano HO, Sugai T, Tokino T, Shinomura Y, Imai K, Suzuki H.

Sci Rep. 2016 May 24;6:26699. doi: 10.1038/srep26699.

49.

Characterization of patient-derived tumor xenografts (PDXs) as models for estrogen receptor positive (ER+HER2- and ER+HER2+) breast cancers.

Kanaya N, Somlo G, Wu J, Frankel P, Kai M, Liu X, Wu SV, Nguyen D, Chan N, Hsieh MY, Kirschenbaum M, Kruper L, Vito C, Badie B, Yim JH, Yuan Y, Hurria A, Peiguo C, Mortimer J, Chen S.

J Steroid Biochem Mol Biol. 2017 Jun;170:65-74. doi: 10.1016/j.jsbmb.2016.05.001. Epub 2016 May 3.

50.

Assessment of epigenetic alterations in early colorectal lesions containing BRAF mutations.

Sawada T, Yamamoto E, Yamano HO, Nojima M, Harada T, Maruyama R, Ashida M, Aoki H, Matsushita HO, Yoshikawa K, Harada E, Tanaka Y, Wakita S, Niinuma T, Kai M, Eizuka M, Sugai T, Suzuki H.

Oncotarget. 2016 Jun 7;7(23):35106-18. doi: 10.18632/oncotarget.9044.

Supplemental Content

Support Center